These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 27567194)

  • 1. Antipsychotic dose in maintenance treatment of schizophrenia: A retrospective study.
    Kumar V; Rao NP; Narasimha V; Sathyanarayanan G; Muralidharan K; Varambally S; Venkatasubramanian G; Gangadhar BN
    Psychiatry Res; 2016 Nov; 245():311-316. PubMed ID: 27567194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antipsychotic treatment in the maintenance phase of schizophrenia: An updated systematic review of the guidelines and algorithms.
    Shimomura Y; Kikuchi Y; Suzuki T; Uchida H; Mimura M; Takeuchi H
    Schizophr Res; 2020 Jan; 215():8-16. PubMed ID: 31784340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
    István S; Agoston T; Tamás T; Zoltán J
    Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
    Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
    J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
    Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC
    JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antipsychotic treatment for schizophrenia in the maintenance phase: a systematic review of the guidelines and algorithms.
    Takeuchi H; Suzuki T; Uchida H; Watanabe K; Mimura M
    Schizophr Res; 2012 Feb; 134(2-3):219-25. PubMed ID: 22154594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single- and multiple-dose pharmacokinetic, safety, and tolerability profiles of olanzapine long-acting injection: an open-label, multicenter, nonrandomized study in patients with schizophrenia.
    Mitchell M; Kothare P; Bergstrom R; Zhao F; Jen KY; Walker D; Johnson J; McDonnell D
    Clin Ther; 2013 Dec; 35(12):1890-908. PubMed ID: 24184052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical practice variations in prescribing antipsychotics for patients with schizophrenia.
    Owen RR; Fischer EP; Kirchner JE; Thrush CR; Williams DK; Cuffel BJ; Elliott CE; Booth BM
    Am J Med Qual; 2003; 18(4):140-6. PubMed ID: 12934949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose reduction of risperidone and olanzapine and estimated dopamine D₂ receptor occupancy in stable patients with schizophrenia: findings from an open-label, randomized, controlled study.
    Takeuchi H; Suzuki T; Bies RR; Remington G; Watanabe K; Mimura M; Uchida H
    J Clin Psychiatry; 2014 Nov; 75(11):1209-14. PubMed ID: 25099201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the individual safe correction of antipsychotic agent polypharmacy in Japanese patients with chronic schizophrenia: validation of safe corrections for antipsychotic polypharmacy and the high-dose method.
    Yamanouchi Y; Sukegawa T; Inagaki A; Inada T; Yoshio T; Yoshimura R; Iwata N
    Int J Neuropsychopharmacol; 2014 Dec; 18(5):. PubMed ID: 25522380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of antipsychotic treatments for schizophrenia: interim 6-month analysis from a prospective observational study (IC-SOHO) comparing olanzapine, quetiapine, risperidone, and haloperidol.
    Dossenbach M; Erol A; el Mahfoud Kessaci M; Shaheen MO; Sunbol MM; Boland J; Hodge A; O'Halloran RA; Bitter I;
    J Clin Psychiatry; 2004 Mar; 65(3):312-21. PubMed ID: 15096069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Who needs antipsychotic maintenance treatment and who does not? Our need to profile and personalize the treatment of first episode psychosis.
    Wunderink L
    Schizophr Res; 2018 Jul; 197():65-66. PubMed ID: 29128323
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety and tolerability of once monthly aripiprazole treatment initiation in adults with schizophrenia stabilized on selected atypical oral antipsychotics other than aripiprazole.
    Potkin SG; Raoufinia A; Mallikaarjun S; Bricmont P; Peters-Strickland T; Kasper W; Baker RA; Eramo A; Sanchez R; McQuade R
    Curr Med Res Opin; 2013 Oct; 29(10):1241-51. PubMed ID: 23822566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramuscular olanzapine vs. intramuscular short-acting antipsychotics: safety, tolerability and the switch to oral antipsychotic medication in patients with schizophrenia or acute mania.
    Chandrasena R; Dvoráková D; Lee SI; Loza N; Mosolov SN; Osváth P; Pregelj P; Walton RJ; Karagianis J; Treuer T
    Int J Clin Pract; 2009 Aug; 63(8):1249-58. PubMed ID: 19558486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness of antipsychotics in schizophrenia and related disorders. Results of a naturalistic study].
    Carpiniello B; Mellino G; Pintore S; Puddu L; Pinna F
    Clin Ter; 2011; 162(4):331-41. PubMed ID: 21912821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How long should antipsychotic treatment be continued after a single episode of schizophrenia?
    Emsley R; Kilian S; Phahladira L
    Curr Opin Psychiatry; 2016 May; 29(3):224-9. PubMed ID: 26967313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pattern and evolution of the prescription of olanzapine during one year: Results of the cohort study ECOL].
    Gasquet I; Flandre P; Heurtebize N; Deal C; Perrin E; Chartier F; Fourrier-Réglat A
    Encephale; 2009 Feb; 35(1):25-31. PubMed ID: 19250990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study.
    Vernal DL; Kapoor S; Al-Jadiri A; Sheridan EM; Borenstein Y; Mormando C; David L; Singh S; Seidman AJ; Carbon M; Gerstenberg M; Saito E; Kane JM; Steinhausen HC; Correll CU
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):535-47. PubMed ID: 26375767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.